From Benchtop to Bedside: A Review of Oncolytic Virotherapy
Oncolytic viruses (OVs) demonstrate the ability to replicate selectively in cancer cells, resulting in antitumor effects by a variety of mechanisms, including direct cell lysis and indirect cell death through immune-mediate host responses. Although the mechanisms of action of OVs are still not fully...
| Published in: | Biomedicines |
|---|---|
| Main Authors: | Audrey H. Choi, Michael P. O’Leary, Yuman Fong, Nanhai G. Chen |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2016-08-01
|
| Subjects: | |
| Online Access: | http://www.mdpi.com/2227-9059/4/3/18 |
Similar Items
Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
by: Hai Zou, et al.
Published: (2023-01-01)
by: Hai Zou, et al.
Published: (2023-01-01)
Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
by: Alberto Reale, et al.
Published: (2021-12-01)
by: Alberto Reale, et al.
Published: (2021-12-01)
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
by: Qing Ji, et al.
Published: (2022-08-01)
by: Qing Ji, et al.
Published: (2022-08-01)
Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-07-01)
by: Ying-Cheng Chen, et al.
Published: (2025-07-01)
Lung cancer and oncolytic virotherapy——enemy's enemy
by: Zhang Li, et al.
Published: (2023-01-01)
by: Zhang Li, et al.
Published: (2023-01-01)
Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01)
by: Jia-Li Zhao, et al.
Published: (2024-11-01)
Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
by: Junior A. Enow, et al.
Published: (2023-11-01)
by: Junior A. Enow, et al.
Published: (2023-11-01)
Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysisResearch in context
by: Poyee Lau, et al.
Published: (2025-08-01)
by: Poyee Lau, et al.
Published: (2025-08-01)
A bibliometric analysis of oncolytic virotherapy combined with immunotherapy
by: Ting Zhang, et al.
Published: (2024-12-01)
by: Ting Zhang, et al.
Published: (2024-12-01)
Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-08-01)
by: Ying-Cheng Chen, et al.
Published: (2025-08-01)
Newcastle Disease Virus Virotherapy: Unveiling Oncolytic Efficacy and Immunomodulation
by: Kawther A. Zaher, et al.
Published: (2024-07-01)
by: Kawther A. Zaher, et al.
Published: (2024-07-01)
Oncolytic viruses-modulated immunogenic cell death, apoptosis and autophagy linking to virotherapy and cancer immune response
by: Yi-Ying Wu, et al.
Published: (2023-03-01)
by: Yi-Ying Wu, et al.
Published: (2023-03-01)
Oncolytic virotherapy for metastatic breast cancer – a case report
by: Benjamin Gesundheit, et al.
Published: (2023-06-01)
by: Benjamin Gesundheit, et al.
Published: (2023-06-01)
Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
by: Mason J. Webb, et al.
Published: (2023-05-01)
by: Mason J. Webb, et al.
Published: (2023-05-01)
The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?
by: Michael L. Franks, et al.
Published: (2024-06-01)
by: Michael L. Franks, et al.
Published: (2024-06-01)
Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis
by: Joseph Malinzi, et al.
Published: (2018-11-01)
by: Joseph Malinzi, et al.
Published: (2018-11-01)
Oncolytics, Cancer-Fighting Viruses from Past to Future: A Literature Review
by: Seyedeh Nasim Mirbahari, et al.
Published: (2024-03-01)
by: Seyedeh Nasim Mirbahari, et al.
Published: (2024-03-01)
Modern Approaches to Enterovirus-Based Oncolytic Immune Virotherapy of Malignant Diseases
by: E. R. Nemtsova, et al.
Published: (2025-07-01)
by: E. R. Nemtsova, et al.
Published: (2025-07-01)
Mechanisms, challenges and future prospects of the oncolytic virotherapy: a comprehensive review
by: Fizza Maryam, et al.
Published: (2024-06-01)
by: Fizza Maryam, et al.
Published: (2024-06-01)
Proliferating Cell Nuclear Antigen in the Era of Oncolytic Virotherapy
by: Amy Kwan, et al.
Published: (2024-08-01)
by: Amy Kwan, et al.
Published: (2024-08-01)
Oncolytic virotherapy in gastric cancer: Towards precision therapeutics
by: Muhammad Ikrama, et al.
Published: (2024-04-01)
by: Muhammad Ikrama, et al.
Published: (2024-04-01)
Biomarker screen for efficacy of oncolytic virotherapy in patient-derived pancreatic cancer culturesResearch in context
by: Theresa E. Schäfer, et al.
Published: (2024-07-01)
by: Theresa E. Schäfer, et al.
Published: (2024-07-01)
Oncolytic Virotherapy for High-Grade Glioma and Current Evidence and Factors to Consider for Incorporation into Clinical Practice
by: Sauson Soldozy, et al.
Published: (2023-06-01)
by: Sauson Soldozy, et al.
Published: (2023-06-01)
Oncolytic virotherapy using neural stem cells as a novel treatment option for glioblastoma multiforme
by: Tanvir Ahmed
Published: (2023-03-01)
by: Tanvir Ahmed
Published: (2023-03-01)
The need for paradigm shift: prognostic significance and implications of standard therapy-related systemic immunosuppression in glioblastoma for immunotherapy and oncolytic virotherapy
by: Aleksei A. Stepanenko, et al.
Published: (2024-02-01)
by: Aleksei A. Stepanenko, et al.
Published: (2024-02-01)
Combining CAR T Cell Therapy and Oncolytic Virotherapy for Pediatric Solid Tumors: A Promising Option
by: Jiasen He, et al.
Published: (2023-01-01)
by: Jiasen He, et al.
Published: (2023-01-01)
To Infection and Beyond: The Multi-Pronged Anti-Cancer Mechanisms of Oncolytic Viruses
by: Kevin A. Cassady, et al.
Published: (2016-02-01)
by: Kevin A. Cassady, et al.
Published: (2016-02-01)
Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors
by: Jérémy Béguin, et al.
Published: (2023-09-01)
by: Jérémy Béguin, et al.
Published: (2023-09-01)
ONCOLYTIC VIROTHERAPY IN GLIOBLASTOMA TREATMENT: PROGRESS AND CHALLENGES IN CLINICAL RESEARCH (LITERATURE REVIEW)
by: O. I. Kit, et al.
Published: (2020-12-01)
by: O. I. Kit, et al.
Published: (2020-12-01)
Translation of oncolytic viruses in sarcoma
by: Steven I. Robinson, et al.
Published: (2024-09-01)
by: Steven I. Robinson, et al.
Published: (2024-09-01)
Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective
by: Palaniyandi Muthukutty, et al.
Published: (2023-07-01)
by: Palaniyandi Muthukutty, et al.
Published: (2023-07-01)
An Unconventional Case Study of Neoadjuvant Oncolytic Virotherapy for Recurrent Breast Cancer
by: Dubravko Forčić, et al.
Published: (2024-08-01)
by: Dubravko Forčić, et al.
Published: (2024-08-01)
Hyaluronidase expression within tumors increases virotherapy efficacy and T cell accumulation
by: Martí Farrera-Sal, et al.
Published: (2021-09-01)
by: Martí Farrera-Sal, et al.
Published: (2021-09-01)
Clinical trials on oncolytic viruses
by: I. V. Golovinov, et al.
Published: (2025-01-01)
by: I. V. Golovinov, et al.
Published: (2025-01-01)
Dendritic cells and natural killer cells: The road to a successful oncolytic virotherapy
by: Matin Ghasemi, et al.
Published: (2023-01-01)
by: Matin Ghasemi, et al.
Published: (2023-01-01)
In Vivo Oncolytic Virotherapy in Murine Models of Hepatocellular Carcinoma: A Systematic Review
by: Muhammad Joan Ailia, et al.
Published: (2022-09-01)
by: Muhammad Joan Ailia, et al.
Published: (2022-09-01)
The progress and research trends in oncolytic virotherapy: The bibliometric analysis from 2000 to 2019
by: Waseem Hassan, et al.
Published: (2023-05-01)
by: Waseem Hassan, et al.
Published: (2023-05-01)
Oncolytic Virotherapy for Cancer: Clinical Experience
by: Shyambabu Chaurasiya, et al.
Published: (2021-04-01)
by: Shyambabu Chaurasiya, et al.
Published: (2021-04-01)
Oncolytic virotherapy against lung cancer: key receptors and signaling pathways of viral entry
by: Wenxun Dong, et al.
Published: (2024-10-01)
by: Wenxun Dong, et al.
Published: (2024-10-01)
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
by: Clara Martín-Carrasco, et al.
Published: (2022-06-01)
by: Clara Martín-Carrasco, et al.
Published: (2022-06-01)
Similar Items
-
Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
by: Hai Zou, et al.
Published: (2023-01-01) -
Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
by: Alberto Reale, et al.
Published: (2021-12-01) -
Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
by: Qing Ji, et al.
Published: (2022-08-01) -
Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-07-01) -
Lung cancer and oncolytic virotherapy——enemy's enemy
by: Zhang Li, et al.
Published: (2023-01-01)
